Position in ABCL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,789,971
+$3,155,874 QoQ
Shares Held
482,799
+165.7% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 150 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Derivatives in ABCL
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$3,164,335
PutShares
403,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF MONTREAL /CAN/ holds $701,516,965 across 82 Biotechnology names. ABCL ranks #17 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
427,448 | $212,326,240 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
942,432 | $73,764,150 | |
| 3 | ARGX |
Argenx SE
|
77,213 | $71,635,902 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
103,247 | $64,378,631 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
242,063 | $58,329,919 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
515,981 | $28,347,995 | |
| 7 | MRNA |
Moderna, Inc.
|
389,789 | $27,296,921 | |
| 8 | CYTK |
Cytokinetics Inc
|
285,688 | $24,337,759 |
All Filings in ABCL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,789,971 | 482,799 | Shares | Defined | 2026-08-12 | |
| 2026-06-30 | $3,164,335 | 403,100 | Put | Defined | 2026-08-12 | |
| 2026-03-31 | $634,097 | 181,690 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $500,547 | 146,359 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $329,503 | 65,508 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $240,404 | 70,089 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $106,891 | 47,934 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $150,739 | 51,447 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $150,833 | 58,013 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $123,310 | 41,659 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $199,895 | 44,127 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $179,539 | 31,443 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $283,010 | 61,524 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $416,294 | 64,442 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $518,878 | 68,817 | Shares | Defined | 2024-06-13 | |
| 2022-12-31 | $642,616 | 63,437 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $1,451,337 | 146,748 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $3,595,971 | 337,650 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $5,411,250 | 555,000 | Call | Defined | 2022-05-12 | |
| 2022-03-31 | $1,252,893 | 128,502 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $1,472,527 | 102,974 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $44,088 | 2,200 | Put | Defined | 2021-11-12 | |
| 2021-09-30 | $2,313,898 | 115,464 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,594,780 | 72,490 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $2,333,833 | 68,723 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $259,306 | 6,444 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||